from    
to    
search  

 


基于选择性断裂惰性键的生物质资源化学
世纪物理情系列讲座(第26讲):Layertronics in twisted 2D semiconductors
环境学术沙龙第696期:从编辑视角谈如何在《自然》系列期刊发文
环境学术沙龙第695期:Publishing with Impact in Royal Society of Chemistry Jour...
报告题目:
Knowledge Preservation, Sharing and Mining by Scilligence Informatics
 报告人:
Dr. Jinbo Lee
Chief Scientific Officer, Scilligence Corporation,USA
报告时间:
2013-03-14 15:00
报告地点:
何添楼310会议室
主办单位:
化学系
  简介:

"Knowledge Preservation, Sharing and Mining by Scilligence Informatics"
Speaker: Jinbo Lee, Chief Scientific Officer, Scilligence Corporation
Abstract
The dawn of digital age and innovative companies like Google and Baidu have made access to information much easily in our daily life. However, industry and academic research is lagging behind in this trend. A lot of companies and academic institutions are still using paper notebooks to document their research and discovery. This makes knowledge preservation and sharing much more difficult. Furthermore, with prevalence of cross-organization collaborations, R&D reorganizations and company merger/acquisition, knowledge can be easily lost in a large pile of unstructured data such as PPT, Word, Excel and PDF. Through case study examples in this presentation, knowledge preservation, sharing and mining makes possible by Scilligence informatics in your R&D environments.

Brief Bio of Speaker
Dr. Jinbo Lee is the co-founder and Chief Scientific Officer of Scilligence Corporation. He has extensive experience in drug discovery and development in both pharmaceutical and biotech companies with senior leadership positions. Most recently as the Head of Chemistry at Ensemble Therapeutics, he was responsible for molecule modeling/cheminformatics, medicinal chemistry, process chemistry, and analytical chemistry. Prior to Ensemble Discovery, Dr. Lee led multi-discipline teams including medicinal chemists, X-ray crystallographers, molecular modelers, pharmacologists and DMPK scientists at Wyeth Pharmaceuticals. He has also worked at Boehringer Ingelheim Pharmaceuticals in the areas of medicinal chemistry, combinatorial chemistry and parallel synthesis. Dr. Lee has in-depth knowledge in multiple diseases areas including oncology, metabolic diseases, neurodegenerative diseases, infectious diseases, and inflammatory and autoimmune diseases. He is an expert in research informatics, medicinal chemistry, structure-based drug design and prodrug design. Dr. Lee received his Ph.D. degree in Organic Chemistry from Princeton University. He was the year 1997 recipient of Roche Award for Excellence in Organic Chemistry. Dr. Lee has many publications in prestigious scientific journals and holds a number of patent/patent applications. He has been an invited speaker in numerous drug discovery and scientific conferences.

今日相关信息
搜索 关联 获取 ---“水木搜索”平台使用...
 
同类别相关信息
二氧化碳参与的新型有机合成化学
“清芬”系列学术报告:Multiplexed i...
Mass spectrometry: What needs to be...
Study of Epigenetic Factors by Adva...
Projector Augmented Wave Method Inc...
学术活动